Customize View
Named by Company
Named by Competitor
Named by Third Party

Recently disclosed competitors only (within the last two years)
Include Competitors for:Current subsidiaries


Competitors

Recently Disclosed Competitors
Competitor's Name
LTM Revenue ($mm)
LTM Date
Source
Apotex Inc.
2,652.75
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Apotex Inc., a pharmaceutical company, researches, develops, and manufactures generic pharmaceuticals. The company manufactures generic pharmaceutical products in various dosages and formats. It also provides business resources, such as Apotex 360 and Apotex Concierge Service. In addition, the company offers services, which include DISpedia, ApoAssist, and Apo-Rosiglitazone services for healthcare professionals and patients. It exports its products to countries across the globe. The company was founded in 1974 and is based in Toronto, Canada with additional locations in USA, Belgium, the Czech Republic, Poland, Spain, Australia, India, New Zealand, and the Netherlands. Apotex Inc. operates as a subsidiary of Apotex Pharmaceutical Holdings Inc.
AstraZeneca Canada Inc.
497.39
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: AstraZeneca Canada Inc., a biopharmaceutical company, engages in discovering, developing, manufacturing, marketing, and selling prescription medicines in Canada. It focuses on various therapeutic areas, such as cardiovascular and metabolic diseases, oncology, respiratory, and inflammation and autoimmunity. The company was founded in 1999 and is based in Mississauga, Canada. Astrazeneca Canada Inc. operates as a subsidiary of AstraZeneca PLC.
Bayer Inc.
536.67
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Bayer Inc. offers healthcare and crop science products in Canada. It offers animal health products for companion animals, such as horses, dogs, cats, and ferrets, as well as farm animals, including cattle, pigs, and chickens; consumer care products, such as over-the-counter drugs that include vitamin and mineral supplements, as well as products for pain and treating vaginal yeast infections; and diabetes care products and services, such as blood glucose meters and test strips, adjustable lancing devices and lancets, and urine reagents. The company also offers pharmaceutical products to prevent and treat cardiovascular diseases, hemophilia, cancer, multiple sclerosis, bacterial and viral infections, and urological disorders; and radiology, interventional, and equipment support services, including medical devices that enable or enhance diagnostic and therapeutic medical procedures for computed tomography, magnetic resonance, and cardiovascular applications, as well as contrast media for use in X-ray, computed tomography, and magnetic resonance imaging. In addition, it provides crop protection products, seed treatment technologies, and plant biotechnology products for farmers. Bayer Inc. was formerly known as Miles Inc. The company was founded in 1863 and is based in Mississauga, Canada with additional offices in Calgary, Regina, Saskatoon, and Lethbridge, Canada. Canada. Bayer Inc. operates as a subsidiary of Bayer Aktiengesellschaft.
Bristol Myers Squibb Canada Co.
82.90
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Bristol Myers Squibb Canada Co., a biopharmaceutical company, discovers and develops medicines for rheumatoid arthritis, stroke, venous thromboembolic events, psychotic conditions, diabetes, HIV, hepatitis C, metastatic melanoma, lung and renal cancer. It also provides research and development services. Bristol Myers Squibb Canada Co. was formerly known as E.R. Squibb & Sons of Canada Limited. The company was incorporated in 2003 and is based in Saint-Laurent, Canada. Bristol Myers Squibb Canada Co. operates as a subsidiary of Bristol-Myers Squibb Company.
GlaxoSmithKline Inc.
113.45
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: GlaxoSmithKline Inc. operates as a research-based pharmaceutical and healthcare company that discovers, develops, and serves medicines, vaccines, and consumer healthcare products to customers in Canada and internationally. The company offers medicines to treat a range of acute and chronic diseases, including respiratory diseases and HIV, as well as off-patent products, generic products, and other local products. It also provides vaccines for rubella, varicella, recombinant hepatitis B, hepatitis A, combined hepatitis A and B, and various combined vaccines, as well as focuses on the research and development of vaccines for meningitis A and C, HIV/AIDS, influenza, rotavirus, the Epstein-Barr virus, hepatitis B and E, allergies, and other diseases. The company offers consumer healthcare products, such as oral health and over-the-counter medicines, as well as skin health and family nutrition. The company was founded in 1902 and is based in Mississauga, Canada with manufacturing sites worldwide. GlaxoSmithKline Inc. operates as a subsidiary of GSK plc.
Janssen Inc.
198.96
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Janssen Inc. is a pharmaceutical company. The company develops products in therapeutic, cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, oncology, and other areas. Its products are used by doctors, nurses and patients, and mothers and fathers. Janssen Inc. was formerly known as Janssen-Ortho Inc. The company was founded in 1941 and is based in Toronto, Canada. Janssen Inc. operates as a subsidiary of Johnson & Johnson.
Johnson & Johnson Inc.
823.11
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Johnson & Johnson Inc. manufactures, markets, and sells consumer health care products for doctors, nurses, mothers, fathers, patients, and others in Canada. It offers baby, oral health, wound, skin and beauty, hair, and eye care products. It provides nicotine replacement therapy, nutritional supplements, and non-prescription drugs. The company also offers ANUSOL, a product that provides relief from hemorrhoids by reducing swelling, soothing itching, and protecting delicate skin; AXERT, an almotriptan malate tablet; adhesive bandages; and a product that provides relief from allergies and allergic reactions. It offers its products through distributors. The company was founded in 1919 and is based in Markham, Canada with additional offices in Montreal, Guelph, and Markham, Canada. Johnson & Johnson Inc. operates as a subsidiary of Kenvue Inc.
Merck Canada Inc.
412.82
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Merck Canada Inc. researches, develops, manufactures, and markets prescription medicines, vaccines, biologic therapies, and consumer care and animal health products. The company offers various vaccines for the prevention of rare diseases, such as measles and mumps, shingles, and cervical cancer; prescription products in various therapeutic areas, such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, and women's health; and consumer healthcare products that help to prevent or treat various common conditions, including allergies, sun care, foot care, nasal and cough/cold care, digestive care, and more. It also offers veterinary medicines, including vaccines, anti-infective and anti-parasitic drugs, a range of fertility management products, performance technologies, pharmaceutical specialty products, delivery solutions, and value-added programs for domestic and farm animals, including dogs, cats, horses, cattle, sheep, pigs, poultry, and fish. In addition, the company focuses on researching on several key therapeutic areas, including cardiovascular, diabetes and obesity, infectious disease, oncology, neurosciences and ophthalmology, women's health and endocrine, and vaccines, as well as bone, respiratory, immunology, and dermatology. It serves customers worldwide. The company was founded in 1982 and is headquartered in Kirkland, Canada. Merck Canada Inc. operates as a subsidiary of Merck & Co. Inc.
Novartis Pharmaceuticals Canada Inc.
663.19
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Novartis Pharmaceuticals Canada Inc. researches, develops, manufactures, and markets pharmaceutical products and medications in Canada. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. Its Sandoz division offers generic medicines, active ingredients, and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosages of anti-infectives. The company was founded in 1996 and is based in Dorval, Canada with an additional office in Boucherville, Canada. Novartis Pharmaceuticals Canada Inc. operates as a subsidiary of Novartis AG.
Pharmascience Inc.
497.39
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Pharmascience Inc. develops, manufactures, markets, and sells prescription, generic, over-the-counter (OTC), and behind-the-counter drug products. The company offers drugs for various therapeutic areas, including oncology, anti-infective, and cardiovascular; (Pr) pms-TRANDOLAPRIL, an angiotensin-converting enzyme inhibitor for the treatment of mild to moderate essential hypertension and the treatment following acute myocardial infarction; and (Pr)pms-PROGESTERONE, a progestin capsule for women with an intact uterus as an adjunct to postmenopausal estrogen replacement therapy to reduce the risk of endometrial hyperplasia and carcinoma. It also offers private label options for OTC drugs in various categories, such as pain management, cough and cold, stomach and gastro-intestinal ailments, and allergies to drug-store retail chains, grocery store banners, and distributors in Canada. In addition, the company offers services in the areas of medical equipment, advertising, and nursing services for pharmacists; and continuing education services. It serves pharmacists, drug wholesalers, retailers, and healthcare providers in Canada and internationally. The company was founded in 1983 and is based in Montreal, Canada with additional offices in Canada, Cyprus, Saudi Arabia, South Korea, Vietnam, and Ukraine. Pharmascience Inc. operates as a subsidiary of Joddes Limited.
Sandoz Canada Inc.
248.70
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Sandoz Canada Inc. develops, manufactures, markets, and distributes generic, biosimilar, and specialty pharmaceutical products. Its portfolio includes various oral, topical, rectal, ophthalmic, and injectable generic products in various forms, such as suspensions, solutions, tablets, capsules, creams, ointments, suppositories, and gelcaps; Sandoz Lenalidomide, a generic for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities; and various formats, including ampoules, vials, bottles, minibags, and transdermal patches. It offers PrSandoz Dimethyl Fumarate Delayed-Release Capsules. The company’s products are used in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, oncology, ophthalmology, transplantation, and women’s health. Sandoz Canada Inc. was formerly known as Sabex, Inc. and changed its name to Sandoz Canada Inc. in September 2005. The company was founded in 1980 and is headquartered in Boucherville, Canada with an additional location in Princeton, new Jersey. Sandoz Canada Inc. operates as a subsidiary of Sandoz International GmbH.
Teva Canada Limited
464.23
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Teva Canada Limited develops, produces, and markets generic pharmaceuticals. The company’s products range from diabetic agents to antibiotics from heart medications to cancer treatments. Its products also include PrBortezomib for injection, which is used for the treatment of patients with previously untreated multiple myeloma who are unsuitable for stem cell transplantation, progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for stem cell transplantation, and patients with mantle cell lymphoma who have relapsed or were refractory to at least one prior therapy; and PrVesicare for the treatment of overactive bladder in adults with symptoms of urge urinary incontinence, urinary urgency, and urinary frequency. In addition, the company offers Teva Pharmacy Solutions, a resource that gives access to accredited CEs and publications, as well as opportunities in the areas of business, science, and practice; and Aermony RespiClick, a device for the treatment of bronchial asthma. It also sells its drugs online. Teva Canada Limited was formerly known as Teva Novopharm Ltd. and changed its name to Teva Canada Limited in February 2010. The company was founded in 1965 and is based in Toronto, Canada. As of April 4, 2000, Teva Canada Limited operates as a subsidiary of Teva Pharmaceutical Industries Limited.
Valeant Canada Ltd.
48.28
-
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Valeant Canada Ltd., a specialty pharmaceutical company, manufactures, distributes, and markets pharmaceutical products in the fields of neurology, psychiatry, pain management, and dermatology. It also focuses on neurology, such as pain management, Parkinson's disease, Epilepsy, multiple sclerosis, Huntington's disease, and ALS; infectious diseases, which include Hepatitis, HIV, SARS, and RSV; Dermatology, including Psoriasis, Eczema, Acne, Rosacea, Actinic Keratoses, Squamous Cell Carcinoma, and anti-fungals; and sleep disorders. Valeant Canada Ltd. was formerly known as ICN Canada Ltd and changed its name to Valeant Canada Ltd. in September 2004. The company was founded in 1956 and is based in Montreal, Canada. Valeant Canada Ltd. operates as a subsidiary of Valeant Pharmaceuticals International, Inc.
Viatris Inc. (NasdaqGS:VTRS)
15,601.90
Jun-30-2023
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) 2022 Form 20-F
Business Description: Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
*denotes proprietary relationship